Cidara Therapeutics Inc. Com New
13F holders, Q4 2025 (December 31)7holders +2
4new positions
2sold out
$220.86avg. 13F price*
At the end of Q4 2025, 7 institutions reported holding Cidara Therapeutics Inc. Com New in their 13F filings, up 2 from Q3 2025. 4 opened new positions and 2 sold out. The largest holders were Crestwood Advisors Group, LLC ($1.7M), Thoroughbred Financial Services, LLC ($1.2M) and EverSource Wealth Advisors, LLC ($69K).
- Company
- Cidara Therapeutics Inc. Com New
- CUSIP
- 171757107
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $1.8M |
| Exits | 2 | $595K |
All 13F filers, Q3 2025 → Q4 2025: 8,744 shares bought and 6,210 shares sold, net +2,534 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Crestwood Advisors Group, LLC | 0.03% | New | 7,683 | $1.7M |
| Thoroughbred Financial Services, LLC | 0.07% | Add +13.6% | 5,602 | $1.2M |
| EverSource Wealth Advisors, LLC | 0.00% | New | 314 | $69K |
| Essential Partners LLC | 0.00% | New | 50 | $11K |
| Rothschild Investment LLC | 0.00% | Add +73.3% | 26 | $6K |
| Farther Finance Advisors, LLC | 0.00% | Add +280.0% | 19 | $4K |
| Bare Financial Services, Inc | 0.00% | New | 2 | $442 |
"% of holder's portfolio" is CIDARA THERAPEUTICS INC COM NEW's weight in each manager's 13F, not the share of Cidara Therapeutics Inc. Com New the manager owns.